These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6880505)

  • 1. [Effect of tranquilizers on short-term memory in patients with borderline forms of neuropsychiatric disorders].
    Maksimenko TV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(5):737-40. PubMed ID: 6880505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relation between the effect of tranquilizers and various features of personality structure among patients with borderline states].
    Aleksandrovskiĭ IuA; Khrulenko-Varnitskiĭ IO; Uvarova LG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1367-76. PubMed ID: 6506985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relation between the dynamics of EEG indices after a single dose of the tranquilizer phenazepam and its efficacy during a course of treatment of patients with borderline neuropsychological disorders].
    Uvarova LG; Titaeva MA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(11):1701-9. PubMed ID: 4082841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinico-pharmacological characteristics of combined administration of tranquilizing agents and other psychotropic drugs].
    Aleksandrovskiĭ IuA; Neznamov GG; Tarnavskiĭ IuB; Valueva LN; Sigunova EA
    Farmakol Toksikol; 1982; 45(3):36-41. PubMed ID: 7095127
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sidnocarb correction of the adverse effects of benzodiazepine tranquilizers].
    Valueva LN; Tozhanova NM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(8):92-7. PubMed ID: 6127851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinico-pharmacologic analysis neurovegetotropic activity of tranquilizers].
    Aleksandrovskiĭ IuA; Ben'kovich BI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(5):743-50. PubMed ID: 6464592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicobiochemical parallels in borderline neuropsychic disorders].
    Ushakov GK; Maslova AF; Kostiunina ZG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(11):1663-6. PubMed ID: 6119860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of bemitil pharmacokinetics in realizing its therapeutic efficacy].
    Boĭko SS; Zherdev VP; Neznamov GG
    Farmakol Toksikol; 1991; 54(2):64-6. PubMed ID: 1679400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The positive effect of alprazolam in the treatment of three patients with borderline personality disorder.
    Faltus FJ
    Am J Psychiatry; 1984 Jun; 141(6):802-3. PubMed ID: 6145360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurological complications following therapy with tranquilizers and their drug correction].
    Ben'kovich BI
    Sov Med; 1983; (7):86-9. PubMed ID: 6623185
    [No Abstract]   [Full Text] [Related]  

  • 11. [Predicting the success of a benzodiazepine discontinuation programme: myths or clinical wisdom?].
    Knoop H; Kan CC; Mickers FC; Barnhoorn D
    Tijdschr Psychiatr; 2006; 48(9):695-703. PubMed ID: 17007475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of corticosteroids on short-term and long-term memory.
    Brunner R; Schaefer D; Hess K; Parzer P; Resch F; Schwab S
    Neurology; 2005 Jan; 64(2):335-7. PubMed ID: 15668434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tranquilizers on critical flicker fusion frequency in the visual system.
    Ben'kovich BI; Marshak OV
    Hum Physiol; 1984; 10(6):435-9. PubMed ID: 6544738
    [No Abstract]   [Full Text] [Related]  

  • 14. A momentary assessment study of the reputed emotional phenotype associated with borderline personality disorder.
    Glaser JP; Van Os J; Mengelers R; Myin-Germeys I
    Psychol Med; 2008 Sep; 38(9):1231-9. PubMed ID: 18047769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzodiazepines in the treatment of depressive, borderline personality, and schizophrenic disorders.
    Schatzberg AF; Cole JO
    Br J Clin Pharmacol; 1981; 11 Suppl 1(Suppl 1):17S-22S. PubMed ID: 6133529
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phenazepam in the treatment of borderline forms of neuropsychiatric disorders].
    Kalandarishvili AS; Bortnik TL; Berdina ES; Lesovskaia TV; Aleksandrovskiĭ IuA
    Sov Med; 1979 Jul; (7):8-14. PubMed ID: 41325
    [No Abstract]   [Full Text] [Related]  

  • 18. Self-reported memory problems in everyday activities in patients with epilepsy treated with antiepileptic drugs.
    Salas-Puig J; Gil-Nagel A; Serratosa JM; Sánchez-Alvarez JC; Elices E; Villanueva V; Carreño M; Alvarez-Carriles J; Porcel J
    Epilepsy Behav; 2009 Apr; 14(4):622-7. PubMed ID: 19435588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental study of the "'rebound syndrome" following discontinuation of prolonged phenazepam administration and possibilities for preventing it].
    Voronina TA; Garibova TL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(7):1056-9. PubMed ID: 7197446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual differences in the effects of clobazam on memory functions--clobazam and memory.
    Koeppen D; Netter P; Fischer C
    Pharmacopsychiatry; 1985 Jan; 18(1):12-4. PubMed ID: 2859617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.